Waldman T - Search Results

1

Identification of STAG2-Mutant Bladder Cancers by Immunohistochemistry.

Park Y, Lelo A, Harris B, Berry DL, Chaldekas K, Kim JS, Waldman T. Park Y, et al. Among authors: waldman t. Methods Mol Biol. 2023;2684:145-151. doi: 10.1007/978-1-0716-3291-8_8. Methods Mol Biol. 2023. PMID: 37410232

2

Requirement for p53 and p21 to sustain G2 arrest after DNA damage.

Bunz F, Dutriaux A, Lengauer C, Waldman T, Zhou S, Brown JP, Sedivy JM, Kinzler KW, Vogelstein B. Bunz F, et al. Among authors: waldman t. Science. 1998 Nov 20;282(5393):1497-501. doi: 10.1126/science.282.5393.1497. Science. 1998. PMID: 9822382

3

Oncogenic mutations of PIK3CA in human cancers.

Samuels Y, Waldman T. Samuels Y, et al. Among authors: waldman t. Curr Top Microbiol Immunol. 2010;347:21-41. doi: 10.1007/82_2010_68. Curr Top Microbiol Immunol. 2010. PMID: 20535651 Free PMC article. Review.

4

Cell-cycle arrest versus cell death in cancer therapy.

Waldman T, Zhang Y, Dillehay L, Yu J, Kinzler K, Vogelstein B, Williams J. Waldman T, et al. Nat Med. 1997 Sep;3(9):1034-6. doi: 10.1038/nm0997-1034. Nat Med. 1997. PMID: 9288734

5

Deletion of PTEN promotes tumorigenic signaling, resistance to anoikis, and altered response to chemotherapeutic agents in human mammary epithelial cells.

Vitolo MI, Weiss MB, Szmacinski M, Tahir K, Waldman T, Park BH, Martin SS, Weber DJ, Bachman KE. Vitolo MI, et al. Among authors: waldman t. Cancer Res. 2009 Nov 1;69(21):8275-83. doi: 10.1158/0008-5472.CAN-09-1067. Epub 2009 Oct 20. Cancer Res. 2009. PMID: 19843859 Free PMC article.

6

IDH1(R132) mutation identified in one human melanoma metastasis, but not correlated with metastases to the brain.

Lopez GY, Reitman ZJ, Solomon D, Waldman T, Bigner DD, McLendon RE, Rosenberg SA, Samuels Y, Yan H. Lopez GY, et al. Among authors: waldman t. Biochem Biophys Res Commun. 2010 Jul 30;398(3):585-7. doi: 10.1016/j.bbrc.2010.06.125. Epub 2010 Jul 13. Biochem Biophys Res Commun. 2010. PMID: 20603105 Free PMC article.

7

Disruption of p53 in human cancer cells alters the responses to therapeutic agents.

Bunz F, Hwang PM, Torrance C, Waldman T, Zhang Y, Dillehay L, Williams J, Lengauer C, Kinzler KW, Vogelstein B. Bunz F, et al. Among authors: waldman t. J Clin Invest. 1999 Aug;104(3):263-9. doi: 10.1172/JCI6863. J Clin Invest. 1999. PMID: 10430607 Free PMC article.

8

p21 is necessary for the p53-mediated G1 arrest in human cancer cells.

Waldman T, Kinzler KW, Vogelstein B. Waldman T, et al. Cancer Res. 1995 Nov 15;55(22):5187-90. Cancer Res. 1995. PMID: 7585571

9

Integrated genomic analyses identify ERRFI1 and TACC3 as glioblastoma-targeted genes.

Duncan CG, Killela PJ, Payne CA, Lampson B, Chen WC, Liu J, Solomon D, Waldman T, Towers AJ, Gregory SG, McDonald KL, McLendon RE, Bigner DD, Yan H. Duncan CG, et al. Among authors: waldman t. Oncotarget. 2010 Aug;1(4):265-77. doi: 10.18632/oncotarget.137. Oncotarget. 2010. PMID: 21113414 Free PMC article.

10

p53 tagged sites from human genomic DNA.

Tokino T, Thiagalingam S, el-Deiry WS, Waldman T, Kinzler KW, Vogelstein B. Tokino T, et al. Among authors: waldman t. Hum Mol Genet. 1994 Sep;3(9):1537-42. doi: 10.1093/hmg/3.9.1537. Hum Mol Genet. 1994. PMID: 7833908

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

88 results

Search Page